To assess the long-term cognitive, behavioral and academic status of preterm children exposed to clinical chorioamnionitis. STUDY DESIGN: In total, 985 infants (o37 weeks and 2500 g at birth) were recruited in a multisite interventional research program. Of these, 43 case-infants were identified based on documented diagnosis of maternal clinical chorioamnionitis. Infants with chorioamnionitis were compared with the remainder of the cohort after controlling for maternal and infant variables. All infants underwent cognitive, behavioral and academic achievement assessments at 3, 8 and 18 years. Standardized cognitive and academic achievement scores were cutoff at 2 s.d.'s below the mean, behavioral scores were cutoff at a T-score 470 and examined with w 2 statistics. Mean scores were evaluated using preliminary bivariate analysis and were followed by multiple regression models predicting child outcomes. RESULT: Overall, children with chorioamnionitis did not have lower scores on any assessment at any age. Children without chorioamnionitis performed significantly lower at 8 years on the Woodcock-Johnson reading subscore and the mean score of the Peabody Picture Vocabulary Test (PPVT). No significant difference persisted to 18-year follow-up. In logistic regression, chorioamnionitis independently predicted higher PPVT scores at 8 years, but not lower performance scores on the Woodcock-Johnson reading subscore. CONCLUSION: Clinical chorioamnionitis was not associated with adverse neurodevelopmental outcomes in this group of preterm infants o37 weeks and 2500 g.
INTRODUCTION
Chorioamnionitis is a serious and undesirable complication of pregnancy, which could lead to significant morbidity and mortality, [1] [2] [3] [4] including cerebral palsy in both the preterm and term neonate. [5] [6] [7] In recent years, attention has been focused on neurodevelopmental outcomes of infants exposed to chorioamnionitis, hypothesizing that fetal inflammatory response to chorioamnionitis may adversely affect other aspects of behavior and cognitive development in addition to neurological injury leading to cerebral palsy. 8 Of these studies, most have not found an association with adverse neurodevelopmental outcomes, including developmental scores in infants or toddlers, 9, 10 or cognitive testing at school age in former preterm infants 11 exposed to subclinical chorioamnionitis. A recent study did identify chorioamnionitis as an independent risk factor for positive screening for autism 12 in former preterm infants. No study to date has published comprehensive longitudinal data of cognitive, academic and behavioral outcomes in infants exposed to clinical chorioamnionitis.
The purpose of this study is to report cognitive, behavioral and academic outcomes of premature infants exposed to chorioamnionitis at 3, 8 and 18 years, hypothesizing that such infants would have evidence of neurodevelopmental impairment in one or more areas.
METHODS

Subject population
Subjects for this study were drawn from the Infant Health and Development Program (IHDP) database. The IHDP study was a multisite (eight centers) randomized clinical trial initiated in the 1980s to determine the efficacy of early intervention on long-term health, cognitive and developmental outcomes of low-birthweight premature infants. Descriptions of IHDP recruitment, study design and intervention have been published in detail elsewhere. [13] [14] [15] [16] Briefly, infants were considered for eligibility if they were 37 weeks or less gestational age with a birthweight of 2500 g or less. Additional eligibility criteria for the original study were primary residence within 45 min of one of the eight participating centers and no severe medical or neurological problems. Ultimately, 985 infants were available for follow-up and analysis. Patients were randomized to a follow-up group or an intervention group, and both groups were followed with baseline medical, developmental and social evaluations. Home visits, child development center enrollment and parent group meetings were additional interventions provided to the intervention group. All subjects were followed to 36 months corrected age to determine benefits of the interventions in the areas of cognitive/behavioral development, and health outcomes. After the clinical trial was completed, the subjects were studied at ages 5, 8 and 18 years and received a broad array of developmental and behavioral assessments. This study is a secondary longitudinal analysis of infants enrolled in the IHDP program, who in addition to being premature were also products of pregnancies complicated by clinical chorioamnionitis.
Identification of subjects with chorioamnionitis
Infants in the database were included in this study if maternal records contained the specific diagnosis of chorioamnionitis. Infants identified as being products of pregnancies complicated by clinical chorioamnionitis were compared with the remainder of the original cohort after controlling for maternal, child and family characteristics (discussed below). This database does not include pathology review of placentas for histological chorioamnionitis and pathological examination was not performed solely to confirm clinical chorioamnionitis; therefore, only the diagnosis made by an obstetrician from the maternal records was considered.
Outcomes
Outcomes considered in this study include cognitive functioning at 3, 8 and 18 years, behavior problems 3 and 8 years and academic achievement at 8 and 18 years (Table 1) . Cognitive, behavior and academic achievement evaluations were performed by trained assessors who were masked to the child's treatment group and history in the original IHDP study (Table 1) .
Cognitive assessment at 3, 8 and 18 years
The Stanford-Binet Intelligence Scale, forms L-M, 17 and The Peabody Picture Vocabulary Test-Revised (PPVT-R) 18 were used to assess cognitive development at 36 months. The Wechsler Intelligence Scale for Children-III 19 and the PPVT-R 18 were used to assess cognitive functioning at 8 years. The Wechsler Abbreviated Scale of Intelligence 20 and the PPVT-Version III 21 were used to assess cognitive functioning at 18 years. All intelligence scales have a mean of 100 with a s.d. of ±15.
Behavior competence at 3 and 8 years
Behavior problems were measured by maternal report using the Child Behavior Checklist (CBCL) for ages 2 and 3 years. 22 The CBCL for ages 3-18 years (1983) 23 was used for maternal report of behavioral problems at 8 years. Results are reported based on T-scores. A cutoff T-score of 470 on the CBCL was used to identify clinically significant behavior problems.
Academic achievement at 8 and 18 years
Reading and Math subscales of the Woodcock-Johnson Tests of Achievement-Revised (1990) (WJTA-R) 24 were used as a measurement of academic achievement at 8 and 18 years. This assessment tool is referenced to a mean of 100 with a s.d. of ±15.
Analysis
Preliminary bivariate analysis (i.e., t-tests) was followed by multiple regression models predicting child outcomes. Regression models included chorioamnionitis and controlled for maternal education, maternal age (years), gender of participant, treatment group status of the participant in the original IHDP study, race, birthweight, gestational age, bronchopulmonary dysplasia (BPD), neonatal index score and total HOME Inventory score at 12 months. BPD was defined as needing supplemental oxygen for 430 days and needing any ventilator therapy with a radiograph consistent with BPD. The neonatal index score is a measure of disease severity in the neonatal intensive care unit used in the IHDP study and is calculated from the total length of stay adjusting for birthweight. 25 The HOME Inventory utilizes a home visitor to assess the environment and stimulation received in the home at 12 months of age. 26 Results from regression analysis are reported but were consistent with more parsimonious bivariate analysis. Standardized cognitive development scores were cut at 2 s.d.'s below the mean and examined with w 2 statistics.
RESULTS
Of the original 985 infants recruited for the IHDP study, 3.9% (43/ 985) were identified as being products of pregnancies complicated by clinical chorioamnionitis. Baseline neonatal comparisons showed that infants with chorioamnionitis had lower birthweights, gestational ages and had longer hospitalizations with more days on the ventilator and more days on supplemental oxygen (13 vs 4 days). Infants with chorioamnionitis also had issues with bronchopulmonary dysplasia and moderate-to-severe respiratory distress (see Table 2 , only the most significant outcomes are shown). There was no difference between the two groups in characteristics, such as infant gender; race; maternal education; maternal alcohol, tobacco or illicit drug use; or prior pregnancies that resulted in preterm delivery (data not shown).
Cognitive and behavioral outcomes at 36 months At age 36 months, 908 infants received IQ testing using the Standford-Binet, 812 the PPVT-R and 888 were available for the total score of the CBCL (Table 3) . Of the 43 infants with chorioamnionitis, 39 (91%) received IQ testing and 35 (81%) received the PPVT-R. There were no significant differences in the percentage of children in the two groups that scored o70 on either measure of cognitive outcome. There was also no difference in mean scores. In total, 38 (88%) infants in the chorioamnionitis group returned for behavioral measures using the CBCL. No significant difference was noted between the two groups in the total score of CBCL or for internalizing and externalizing subscales (data not shown for subscales of the CBCL).
Cognitive, behavioral and academic achievement outcomes at 8 years In all, 869 infants received cognitive testing using the Weschler Intelligence Scale for Children-III (WISC-III) at age 8 years and 863 infants received the PPVT-R (Table 4) . A total of 870 infants were available for the total score of the CBCL (1983). For academic achievement at 8 years, 848 received the reading portion of the WJTA-R and 868 received the math portion.
Of the original 43 infants with chorioamnionitis, 34 (79%) received the PPVT-R, and 36 (84%) the WISC-III and the reading and math subscales of WJTA-R. The non-chorioamnionitis group had a significantly higher number of participants who were o2 s.d. on the reading subscale of the WJTA-R (0 vs 9.7%, P ¼ 0.049). The mean scores of the reading subscale did not differ significantly between the two groups. The non-chorioamnionitis group had a significantly lower mean score on the PPTV-R (93 vs 85, P ¼ 0.008). The non-chorioamnionitis group had more children who fell o2 s.d. below the mean of the PPVT-R (8.8 vs 22.6%, P ¼ 0.058) and was trending toward significance. Mean verbal subscale scores of the WISC-III were not significantly different between the two groups. The mean score of the chorioamnionitis group was 96 and the non-chorioamnionitis group was 93 (P ¼ 0.52, data not shown).
In all, 36 (84%) children with chorioamnionitis received the CBCL (1983). We found no significant difference between the two groups in the total score of CBCL or individual scores for internalizing and externalizing behavior (see Table 4 , data not shown for subscales of the CBCL).
Logistic regression Two evaluations at 8 years yielded a significant result in favor of the group with chorioamnionitis. After logistic regression, chorioamnionitis was identified to be an independent factor in the mean score of the PPVT at 8 years (P ¼ 0.01), but was not an independent factor in the W-J reading subscore at 8 years (P ¼ 0.99).
Cognitive and academic achievement outcomes at 18 years For cognitive outcomes, 614 participants received IQ testing and 611 received the PPVT-Version III (Table 5) . For academic achievement, 606 participants received the reading and 608 the math subscales of the WJTA-R.
In all, 26 (60%) of the chorioamnionitis group returned for cognitive testing using the Wechsler Abbreviated Scale of Intelligence and PPVT-Version III. The finding of a significantly higher total mean score in the non-chorioamnionitis group for the PPVT-R at 8 years did not persist to 18 years when both groups were tested using the PPVT-III. The chorioamnionitis group also had significantly higher mean verbal IQ score of the Wechsler Abbreviated Scale of Intelligence. There was no significant difference in the percentage of participants of the two groups that fell o2 s.d. below the mean. In all, 26 (60%) of the chorioamnionitis group returned for academic testing in the areas of math and reading using the WJTA-R. We did not detect a significant difference in the percentage of participants who were o70 for the two subscale measures or the mean scores of the two groups.
DISCUSSION
This study is a secondary longitudinal analysis of the IHDP database evaluating long-term outcomes of infants with a history of clinical chorioamnionitis at o37 weeks gestation and birthweight o2500 g. The recruitment for the original IHDP study was completed in 1985, which allowed us to follow a group of preterm infants with a history of chorioamnionitis through 18 years of age. The hypothesis was that clinical chorioamnionitis would be associated with significant adverse behavioral, cognitive or academic outcomes at 3, 8 and 18 years. No such adverse outcomes were found. Recently, Andrews et al.
11 evaluated children with subclinical chorioamnionitis and found no association with adverse cognitive outcomes at school age. This study provided some insight into outcomes of pregnancies affected by premature rupture of membranes and preterm labor in which placental inflammation may not produce overt clinical signs of chorioamnionitis. Although other studies have provided valuable information on outcomes, 10, 27, 28 albeit most from the setting of histological chorioamnionitis, none have reported outcomes over age groups to 18 years in multiple domains. The original IHDP study and subsequent database includes a wealth of outcomes, allowing us to report on behavioral and academic performance in addition to cognitive outcomes transcending multiple age groups, which has not been reported before in the literature.
It is interesting to note that we did detect a significant difference in specific 8-year tests, including the mean score of the PPVT-R at 8 years and group percentage o2 s.d. of the WJTA-R reading subscore in favoring the infants with a history of chorioamnionitis. There was no significant difference in the two groups that persisted to the 18 years, but the trend of higher mean scores and fewer total numbers o2 s.d. did continue. In regards to the PPVT at 8 years, both groups ultimately had mean scores that were within 1 s.d. of the mean score for the test (mean ¼ 100, 1 s.d. ¼ ± 15). Overall, the data indicate that chorioamnionitis does not contribute to adverse neurodevelopmental outcomes in this group of preterm infants.
This study has several weaknesses, the most relevant of which is dependence on the specific diagnosis of chorioamnionitis in the maternal records to identify infants for this study. This was due to the method of neonatal and maternal data collection once an infant was identified as a candidate and consented for the original IHDP trial. Histological review of placentas of pregnancies complicated clinical chorioamnionitis was not pursued as it was not thought to be a critical factor in the IHDP trial's original goals. Nevertheless, the neonatal course of identified infants differed significantly from the remainder of the cohort and were consistent with known complications of preterm infants exposed to chorioamnionitis 1, 4, 9, 29 (Table 2 ) at the time of original recruitment. We thus believe that our group of infants identified as having clinical chorioamnionitis was truly exposed to intrauterine inflammation. Also, the original study was not designed or powered to evaluate peripartum complications such as chorioamnionitis on neurodevelopmental outcomes.
This study has several strengths including extended length of follow-up and the longitudinal nature of the study with thorough evaluations at critical points of development using standardized tools for cognitive, behavioral and academic achievement administered by child psychologists, developmental pediatricians and trained support staff. All tools utilized were the best available tools at that time. Other strengths include the extensive neonatal outcome data collected by trained research personnel who were not aware of chorioamnionitis status. Finally, the overall retention in this database from age group to age group was excellent.
Overall, this study provides some insight on the effects of chorioamnionitis on many long-term neurodevelopmental outcomes. In addition, these results can be viewed from a historical viewpoint as original recruitment was in an era before the routine use of antenatal steroids and surfactant replacement for hyaline membrane disease. Mean scores were reported to the nearest whole number.
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